Related Experiment Videos
Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging
Insights
A new clinical staging method for necrotizing enterocolitis (NEC) in infants guides treatment. This approach, with graded interventions, showed high survival rates, supporting combination antimicrobial therapy for NEC.
Area of Science:
- Neonatalogy
- Pediatric Surgery
- Infectious Diseases
Background:
- Necrotizing enterocolitis (NEC) is a serious gastrointestinal condition in neonates.
- Effective clinical staging and treatment protocols for NEC are crucial for improving outcomes.
Purpose of the Study:
- To propose and evaluate a method of clinical staging for infants diagnosed with necrotizing enterocolitis (NEC).
- To correlate NEC stages with specific treatment interventions and assess patient survival rates.
Main Methods:
- A graded intervention strategy was applied to 48 infants based on their assigned NEC stage at diagnosis.
- Stage I: diagnostic and supportive measures; Stage II: medical management with parenteral and gavage aminoglycoside antibiotics; Stage III: surgical intervention.
- Bacteriologic evaluation of gastrointestinal microflora and blood cultures were performed.
Main Results:
- All Stage I infants survived. Of the 38 Stage II and III infants, 85% survived the acute episode of NEC.
- Diverse enteric organisms, including anaerobes, were identified in the gastrointestinal tract.
- Enteric organisms were found in the blood of four infants who died from NEC.
- Sequential cultures indicated alterations in microflora during gavage antibiotic therapy.
Conclusions:
- The proposed clinical staging method effectively guides graded interventions for NEC in infants.
- Combination antimicrobial therapy appears to be a valuable component in managing NEC, supported by observed microflora alterations and survival data.
Abstract:
A method of clinical staging for infants with necrotizing enterocolitis (NEC) is proposed. On the basis of assigned stage at the time of diagnosis, 48 infants were treated with graded intervention. For Stage I infants, vigorous diagnostic and supportive measures are appropriate. Stage II infants are treated medically, including parenteral and gavage aminoglycoside antibiotic, and Stage III patients require operation. All Stage I patients survived, and 32 of 38 Stage II and III patients (85%) survived the acute episode of NEC. Bacteriologic evaluation of the gastrointestinal microflora in these neonates has revealed a wide range of enteric organisms including anaerobes. Enteric organisms were cultured from the blood of four infants dying of NEC. Sequential cultures of enteric organisms reveal an alteration of flora during gavage antibiotic therapy. These studies support the use of combination antimicrobial therapy in the treatment of infants with NEC.